| 1 |
29805751 | The cyclin-dependent kinase inhibitor flavopiridol (alvocidib) inhibits metastasis of human osteosarcoma cells. | 2018 May 4 |
1 |
| 2 |
27461656 | Flavopiridol's antiproliferative effects in glioblastoma multiforme. | 2016 Apr-Jun |
1 |
| 3 |
25216351 | Induced growth inhibition, cell cycle arrest and apoptosis in CD133+/CD44+ prostate cancer stem cells by flavopiridol. | 2014 Nov |
1 |
| 4 |
22948151 | Identification of HEXIM1 as a positive regulator of p53. | 2012 Oct 19 |
1 |
| 5 |
20008633 | Flavopiridol, fludarabine, and rituximab in mantle cell lymphoma and indolent B-cell lymphoproliferative disorders. | 2010 Jan 20 |
1 |
| 6 |
21092078 | Potent inhibition of rhabdoid tumor cells by combination of flavopiridol and 4OH-tamoxifen. | 2010 Nov 19 |
6 |
| 7 |
21159612 | Combination of vorinostat and flavopiridol is selectively cytotoxic to multidrug-resistant neuroblastoma cell lines with mutant TP53. | 2010 Dec |
4 |
| 8 |
18381438 | The cyclin-dependent kinase inhibitor flavopiridol potentiates the effects of topoisomerase I poisons by suppressing Rad51 expression in a p53-dependent manner. | 2008 Apr 1 |
6 |
| 9 |
18640498 | Flavopiridol potentiates the cytotoxic effects of radiation in radioresistant tumor cells in which p53 is mutated or Bcl-2 is overexpressed. | 2008 Aug 1 |
4 |
| 10 |
16503551 | Flavopiridol in patients with relapsed or refractory multiple myeloma: a phase 2 trial with clinical and pharmacodynamic end-points. | 2006 Mar |
1 |
| 11 |
15897584 | A phase I clinical trial of the sequential combination of irinotecan followed by flavopiridol. | 2005 May 15 |
1 |
| 12 |
16115936 | Phase 1 trial of flavopiridol combined with cisplatin or carboplatin in patients with advanced malignancies with the assessment of pharmacokinetic and pharmacodynamic end points. | 2005 Aug 15 |
1 |
| 13 |
15150125 | Flavopiridol induces p53 via initial inhibition of Mdm2 and p21 and, independently of p53, sensitizes apoptosis-reluctant cells to tumor necrosis factor. | 2004 May 15 |
1 |
| 14 |
15297405 | Phase I trial of the cyclin-dependent kinase inhibitor flavopiridol in combination with docetaxel in patients with metastatic breast cancer. | 2004 Aug 1 |
1 |
| 15 |
12688354 | Flavopiridol induces apoptosis in B-cell chronic lymphocytic leukaemia cells through a p38 and ERK MAP kinase-dependent mechanism. | 2003 Feb |
1 |
| 16 |
12432259 | Flavopiridol inversely affects p21(WAF1/CIP1) and p53 and protects p21-sensitive cells from paclitaxel. | 2002 Jul-Aug |
3 |
| 17 |
11482875 | Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes. | 2001 May-Jun |
1 |
| 18 |
10811119 | Flavopiridol binds to duplex DNA. | 2000 May 1 |
1 |
| 19 |
10537362 | Flavopiridol induces cell cycle arrest and p53-independent apoptosis in non-small cell lung cancer cell lines. | 1999 Oct |
4 |
| 20 |
9808574 | Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53. | 1998 Nov 15 |
2 |